Global Gene Therapy-based Drug Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Description

According to our (Global Info Research) latest study, the global Gene Therapy-based Drug market size was valued at USD 9325.4 million in 2023 and is forecast to a readjusted size of USD 32040 million by 2030 with a CAGR of 19.3% during review period.

Gene therapy is an experimental technique that uses genes to treat or prevent disease. In the future, this technique may allow doctors to treat a disorder by inserting a gene into a patient's cells instead of using drugs or surgery.

The advanced therapy based on gene market is driven by the potential to revolutionize healthcare by offering personalized and targeted treatments for genetic disorders and other diseases. Advanced therapy based on gene includes gene therapy, cell therapy, and gene editing techniques, which aim to modify or replace faulty genes to treat or cure diseases at the genetic level. The rise in the understanding of genetic mechanisms and advancements in biotechnology and genetic engineering contribute to market growth as these therapies hold promise for previously untreatable conditions. Moreover, increasing investment in research and clinical trials and the support from regulatory agencies for accelerated approval further boost the development and commercialization of advanced gene therapies. However, the market also faces challenges, including the complexity of manufacturing and delivering gene-based therapies, safety concerns related to viral vectors and off-target effects in gene editing, and high treatment costs. Additionally, addressing regulatory requirements and ensuring accessibility and affordability of advanced gene therapies can pose obstacles for broader adoption. To succeed, companies must focus on research and development to advance the safety and efficacy of gene-based therapies, collaborate with healthcare stakeholders to build robust infrastructure, and address the challenges to fully realize the transformative potential of advanced therapy based on gene in modern medicine.

The Global Info Research report includes an overview of the development of the Gene Therapy-based Drug industry chain, the market status of Neurological Diseases (Viral Gene Delivery System, Non-viral Gene Delivery System), Cancer (Viral Gene Delivery System, Non-viral Gene Delivery System), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Gene Therapy-based Drug.

Regionally, the report analyzes the Gene Therapy-based Drug markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Gene Therapy-based Drug market, with robust domestic demand, supportive policies, and a strong manufacturing base.

Key Features:
The report presents comprehensive understanding of the Gene Therapy-based Drug market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Gene Therapy-based Drug industry.

The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Viral Gene Delivery System, Non-viral Gene Delivery System).

Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Gene Therapy-based Drug market.

Regional Analysis: The report involves examining the Gene Therapy-based Drug market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.

Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Gene Therapy-based Drug market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.

The report also involves a more granular approach to Gene Therapy-based Drug:
Company Analysis: Report covers individual Gene Therapy-based Drug players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.

Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Gene Therapy-based Drug This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Neurological Diseases, Cancer).

Technology Analysis: Report covers specific technologies relevant to Gene Therapy-based Drug. It assesses the current state, advancements, and potential future developments in Gene Therapy-based Drug areas.

Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Gene Therapy-based Drug market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.

Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.

Market Segmentation
Gene Therapy-based Drug market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.

Market segment by Type
    Viral Gene Delivery System
    Non-viral Gene Delivery System

Market segment by Application
    Neurological Diseases
    Cancer
    Other

Market segment by players, this report covers
    Biogen
    Novartis
    Gilead Sciences
    Sarepta Therapeutics
    Alnylam Pharmaceuticals
    Amgen
    Spark Therapeutics
    Akcea Therapeutics
    bluebird bio
    Sunway Biotech
    SIBIONO
    AnGes
    Orchard Therapeutics
    Human Stem Cells Institute

Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
    South America (Brazil, Argentina and Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Gene Therapy-based Drug product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Gene Therapy-based Drug, with revenue, gross margin and global market share of Gene Therapy-based Drug from 2019 to 2024.
Chapter 3, the Gene Therapy-based Drug competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Gene Therapy-based Drug market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Gene Therapy-based Drug.
Chapter 13, to describe Gene Therapy-based Drug research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Gene Therapy-based Drug
    1.2 Market Estimation Caveats and Base Year
    1.3 Classification of Gene Therapy-based Drug by Type
        1.3.1 Overview: Global Gene Therapy-based Drug Market Size by Type: 2019 Versus 2023 Versus 2030
        1.3.2 Global Gene Therapy-based Drug Consumption Value Market Share by Type in 2023
        1.3.3 Viral Gene Delivery System
        1.3.4 Non-viral Gene Delivery System
    1.4 Global Gene Therapy-based Drug Market by Application
        1.4.1 Overview: Global Gene Therapy-based Drug Market Size by Application: 2019 Versus 2023 Versus 2030
        1.4.2 Neurological Diseases
        1.4.3 Cancer
        1.4.4 Other
    1.5 Global Gene Therapy-based Drug Market Size & Forecast
    1.6 Global Gene Therapy-based Drug Market Size and Forecast by Region
        1.6.1 Global Gene Therapy-based Drug Market Size by Region: 2019 VS 2023 VS 2030
        1.6.2 Global Gene Therapy-based Drug Market Size by Region, (2019-2030)
        1.6.3 North America Gene Therapy-based Drug Market Size and Prospect (2019-2030)
        1.6.4 Europe Gene Therapy-based Drug Market Size and Prospect (2019-2030)
        1.6.5 Asia-Pacific Gene Therapy-based Drug Market Size and Prospect (2019-2030)
        1.6.6 South America Gene Therapy-based Drug Market Size and Prospect (2019-2030)
        1.6.7 Middle East and Africa Gene Therapy-based Drug Market Size and Prospect (2019-2030)

2 Company Profiles
    2.1 Biogen
        2.1.1 Biogen Details
        2.1.2 Biogen Major Business
        2.1.3 Biogen Gene Therapy-based Drug Product and Solutions
        2.1.4 Biogen Gene Therapy-based Drug Revenue, Gross Margin and Market Share (2019-2024)
        2.1.5 Biogen Recent Developments and Future Plans
    2.2 Novartis
        2.2.1 Novartis Details
        2.2.2 Novartis Major Business
        2.2.3 Novartis Gene Therapy-based Drug Product and Solutions
        2.2.4 Novartis Gene Therapy-based Drug Revenue, Gross Margin and Market Share (2019-2024)
        2.2.5 Novartis Recent Developments and Future Plans
    2.3 Gilead Sciences
        2.3.1 Gilead Sciences Details
        2.3.2 Gilead Sciences Major Business
        2.3.3 Gilead Sciences Gene Therapy-based Drug Product and Solutions
        2.3.4 Gilead Sciences Gene Therapy-based Drug Revenue, Gross Margin and Market Share (2019-2024)
        2.3.5 Gilead Sciences Recent Developments and Future Plans
    2.4 Sarepta Therapeutics
        2.4.1 Sarepta Therapeutics Details
        2.4.2 Sarepta Therapeutics Major Business
        2.4.3 Sarepta Therapeutics Gene Therapy-based Drug Product and Solutions
        2.4.4 Sarepta Therapeutics Gene Therapy-based Drug Revenue, Gross Margin and Market Share (2019-2024)
        2.4.5 Sarepta Therapeutics Recent Developments and Future Plans
    2.5 Alnylam Pharmaceuticals
        2.5.1 Alnylam Pharmaceuticals Details
        2.5.2 Alnylam Pharmaceuticals Major Business
        2.5.3 Alnylam Pharmaceuticals Gene Therapy-based Drug Product and Solutions
        2.5.4 Alnylam Pharmaceuticals Gene Therapy-based Drug Revenue, Gross Margin and Market Share (2019-2024)
        2.5.5 Alnylam Pharmaceuticals Recent Developments and Future Plans
    2.6 Amgen
        2.6.1 Amgen Details
        2.6.2 Amgen Major Business
        2.6.3 Amgen Gene Therapy-based Drug Product and Solutions
        2.6.4 Amgen Gene Therapy-based Drug Revenue, Gross Margin and Market Share (2019-2024)
        2.6.5 Amgen Recent Developments and Future Plans
    2.7 Spark Therapeutics
        2.7.1 Spark Therapeutics Details
        2.7.2 Spark Therapeutics Major Business
        2.7.3 Spark Therapeutics Gene Therapy-based Drug Product and Solutions
        2.7.4 Spark Therapeutics Gene Therapy-based Drug Revenue, Gross Margin and Market Share (2019-2024)
        2.7.5 Spark Therapeutics Recent Developments and Future Plans
    2.8 Akcea Therapeutics
        2.8.1 Akcea Therapeutics Details
        2.8.2 Akcea Therapeutics Major Business
        2.8.3 Akcea Therapeutics Gene Therapy-based Drug Product and Solutions
        2.8.4 Akcea Therapeutics Gene Therapy-based Drug Revenue, Gross Margin and Market Share (2019-2024)
        2.8.5 Akcea Therapeutics Recent Developments and Future Plans
    2.9 bluebird bio
        2.9.1 bluebird bio Details
        2.9.2 bluebird bio Major Business
        2.9.3 bluebird bio Gene Therapy-based Drug Product and Solutions
        2.9.4 bluebird bio Gene Therapy-based Drug Revenue, Gross Margin and Market Share (2019-2024)
        2.9.5 bluebird bio Recent Developments and Future Plans
    2.10 Sunway Biotech
        2.10.1 Sunway Biotech Details
        2.10.2 Sunway Biotech Major Business
        2.10.3 Sunway Biotech Gene Therapy-based Drug Product and Solutions
        2.10.4 Sunway Biotech Gene Therapy-based Drug Revenue, Gross Margin and Market Share (2019-2024)
        2.10.5 Sunway Biotech Recent Developments and Future Plans
    2.11 SIBIONO
        2.11.1 SIBIONO Details
        2.11.2 SIBIONO Major Business
        2.11.3 SIBIONO Gene Therapy-based Drug Product and Solutions
        2.11.4 SIBIONO Gene Therapy-based Drug Revenue, Gross Margin and Market Share (2019-2024)
        2.11.5 SIBIONO Recent Developments and Future Plans
    2.12 AnGes
        2.12.1 AnGes Details
        2.12.2 AnGes Major Business
        2.12.3 AnGes Gene Therapy-based Drug Product and Solutions
        2.12.4 AnGes Gene Therapy-based Drug Revenue, Gross Margin and Market Share (2019-2024)
        2.12.5 AnGes Recent Developments and Future Plans
    2.13 Orchard Therapeutics
        2.13.1 Orchard Therapeutics Details
        2.13.2 Orchard Therapeutics Major Business
        2.13.3 Orchard Therapeutics Gene Therapy-based Drug Product and Solutions
        2.13.4 Orchard Therapeutics Gene Therapy-based Drug Revenue, Gross Margin and Market Share (2019-2024)
        2.13.5 Orchard Therapeutics Recent Developments and Future Plans
    2.14 Human Stem Cells Institute
        2.14.1 Human Stem Cells Institute Details
        2.14.2 Human Stem Cells Institute Major Business
        2.14.3 Human Stem Cells Institute Gene Therapy-based Drug Product and Solutions
        2.14.4 Human Stem Cells Institute Gene Therapy-based Drug Revenue, Gross Margin and Market Share (2019-2024)
        2.14.5 Human Stem Cells Institute Recent Developments and Future Plans

3 Market Competition, by Players
    3.1 Global Gene Therapy-based Drug Revenue and Share by Players (2019-2024)
    3.2 Market Share Analysis (2023)
        3.2.1 Market Share of Gene Therapy-based Drug by Company Revenue
        3.2.2 Top 3 Gene Therapy-based Drug Players Market Share in 2023
        3.2.3 Top 6 Gene Therapy-based Drug Players Market Share in 2023
    3.3 Gene Therapy-based Drug Market: Overall Company Footprint Analysis
        3.3.1 Gene Therapy-based Drug Market: Region Footprint
        3.3.2 Gene Therapy-based Drug Market: Company Product Type Footprint
        3.3.3 Gene Therapy-based Drug Market: Company Product Application Footprint
    3.4 New Market Entrants and Barriers to Market Entry
    3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type
    4.1 Global Gene Therapy-based Drug Consumption Value and Market Share by Type (2019-2024)
    4.2 Global Gene Therapy-based Drug Market Forecast by Type (2025-2030)

5 Market Size Segment by Application
    5.1 Global Gene Therapy-based Drug Consumption Value Market Share by Application (2019-2024)
    5.2 Global Gene Therapy-based Drug Market Forecast by Application (2025-2030)

6 North America
    6.1 North America Gene Therapy-based Drug Consumption Value by Type (2019-2030)
    6.2 North America Gene Therapy-based Drug Consumption Value by Application (2019-2030)
    6.3 North America Gene Therapy-based Drug Market Size by Country
        6.3.1 North America Gene Therapy-based Drug Consumption Value by Country (2019-2030)
        6.3.2 United States Gene Therapy-based Drug Market Size and Forecast (2019-2030)
        6.3.3 Canada Gene Therapy-based Drug Market Size and Forecast (2019-2030)
        6.3.4 Mexico Gene Therapy-based Drug Market Size and Forecast (2019-2030)

7 Europe
    7.1 Europe Gene Therapy-based Drug Consumption Value by Type (2019-2030)
    7.2 Europe Gene Therapy-based Drug Consumption Value by Application (2019-2030)
    7.3 Europe Gene Therapy-based Drug Market Size by Country
        7.3.1 Europe Gene Therapy-based Drug Consumption Value by Country (2019-2030)
        7.3.2 Germany Gene Therapy-based Drug Market Size and Forecast (2019-2030)
        7.3.3 France Gene Therapy-based Drug Market Size and Forecast (2019-2030)
        7.3.4 United Kingdom Gene Therapy-based Drug Market Size and Forecast (2019-2030)
        7.3.5 Russia Gene Therapy-based Drug Market Size and Forecast (2019-2030)
        7.3.6 Italy Gene Therapy-based Drug Market Size and Forecast (2019-2030)

8 Asia-Pacific
    8.1 Asia-Pacific Gene Therapy-based Drug Consumption Value by Type (2019-2030)
    8.2 Asia-Pacific Gene Therapy-based Drug Consumption Value by Application (2019-2030)
    8.3 Asia-Pacific Gene Therapy-based Drug Market Size by Region
        8.3.1 Asia-Pacific Gene Therapy-based Drug Consumption Value by Region (2019-2030)
        8.3.2 China Gene Therapy-based Drug Market Size and Forecast (2019-2030)
        8.3.3 Japan Gene Therapy-based Drug Market Size and Forecast (2019-2030)
        8.3.4 South Korea Gene Therapy-based Drug Market Size and Forecast (2019-2030)
        8.3.5 India Gene Therapy-based Drug Market Size and Forecast (2019-2030)
        8.3.6 Southeast Asia Gene Therapy-based Drug Market Size and Forecast (2019-2030)
        8.3.7 Australia Gene Therapy-based Drug Market Size and Forecast (2019-2030)

9 South America
    9.1 South America Gene Therapy-based Drug Consumption Value by Type (2019-2030)
    9.2 South America Gene Therapy-based Drug Consumption Value by Application (2019-2030)
    9.3 South America Gene Therapy-based Drug Market Size by Country
        9.3.1 South America Gene Therapy-based Drug Consumption Value by Country (2019-2030)
        9.3.2 Brazil Gene Therapy-based Drug Market Size and Forecast (2019-2030)
        9.3.3 Argentina Gene Therapy-based Drug Market Size and Forecast (2019-2030)

10 Middle East & Africa
    10.1 Middle East & Africa Gene Therapy-based Drug Consumption Value by Type (2019-2030)
    10.2 Middle East & Africa Gene Therapy-based Drug Consumption Value by Application (2019-2030)
    10.3 Middle East & Africa Gene Therapy-based Drug Market Size by Country
        10.3.1 Middle East & Africa Gene Therapy-based Drug Consumption Value by Country (2019-2030)
        10.3.2 Turkey Gene Therapy-based Drug Market Size and Forecast (2019-2030)
        10.3.3 Saudi Arabia Gene Therapy-based Drug Market Size and Forecast (2019-2030)
        10.3.4 UAE Gene Therapy-based Drug Market Size and Forecast (2019-2030)

11 Market Dynamics
    11.1 Gene Therapy-based Drug Market Drivers
    11.2 Gene Therapy-based Drug Market Restraints
    11.3 Gene Therapy-based Drug Trends Analysis
    11.4 Porters Five Forces Analysis
        11.4.1 Threat of New Entrants
        11.4.2 Bargaining Power of Suppliers
        11.4.3 Bargaining Power of Buyers
        11.4.4 Threat of Substitutes
        11.4.5 Competitive Rivalry

12 Industry Chain Analysis
    12.1 Gene Therapy-based Drug Industry Chain
    12.2 Gene Therapy-based Drug Upstream Analysis
    12.3 Gene Therapy-based Drug Midstream Analysis
    12.4 Gene Therapy-based Drug Downstream Analysis

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology
    14.2 Research Process and Data Source
    14.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Gene Therapy-based Drug Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Table 2. Global Gene Therapy-based Drug Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
    Table 3. Global Gene Therapy-based Drug Consumption Value by Region (2019-2024) & (USD Million)
    Table 4. Global Gene Therapy-based Drug Consumption Value by Region (2025-2030) & (USD Million)
    Table 5. Biogen Company Information, Head Office, and Major Competitors
    Table 6. Biogen Major Business
    Table 7. Biogen Gene Therapy-based Drug Product and Solutions
    Table 8. Biogen Gene Therapy-based Drug Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 9. Biogen Recent Developments and Future Plans
    Table 10. Novartis Company Information, Head Office, and Major Competitors
    Table 11. Novartis Major Business
    Table 12. Novartis Gene Therapy-based Drug Product and Solutions
    Table 13. Novartis Gene Therapy-based Drug Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 14. Novartis Recent Developments and Future Plans
    Table 15. Gilead Sciences Company Information, Head Office, and Major Competitors
    Table 16. Gilead Sciences Major Business
    Table 17. Gilead Sciences Gene Therapy-based Drug Product and Solutions
    Table 18. Gilead Sciences Gene Therapy-based Drug Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 19. Gilead Sciences Recent Developments and Future Plans
    Table 20. Sarepta Therapeutics Company Information, Head Office, and Major Competitors
    Table 21. Sarepta Therapeutics Major Business
    Table 22. Sarepta Therapeutics Gene Therapy-based Drug Product and Solutions
    Table 23. Sarepta Therapeutics Gene Therapy-based Drug Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 24. Sarepta Therapeutics Recent Developments and Future Plans
    Table 25. Alnylam Pharmaceuticals Company Information, Head Office, and Major Competitors
    Table 26. Alnylam Pharmaceuticals Major Business
    Table 27. Alnylam Pharmaceuticals Gene Therapy-based Drug Product and Solutions
    Table 28. Alnylam Pharmaceuticals Gene Therapy-based Drug Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 29. Alnylam Pharmaceuticals Recent Developments and Future Plans
    Table 30. Amgen Company Information, Head Office, and Major Competitors
    Table 31. Amgen Major Business
    Table 32. Amgen Gene Therapy-based Drug Product and Solutions
    Table 33. Amgen Gene Therapy-based Drug Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 34. Amgen Recent Developments and Future Plans
    Table 35. Spark Therapeutics Company Information, Head Office, and Major Competitors
    Table 36. Spark Therapeutics Major Business
    Table 37. Spark Therapeutics Gene Therapy-based Drug Product and Solutions
    Table 38. Spark Therapeutics Gene Therapy-based Drug Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 39. Spark Therapeutics Recent Developments and Future Plans
    Table 40. Akcea Therapeutics Company Information, Head Office, and Major Competitors
    Table 41. Akcea Therapeutics Major Business
    Table 42. Akcea Therapeutics Gene Therapy-based Drug Product and Solutions
    Table 43. Akcea Therapeutics Gene Therapy-based Drug Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 44. Akcea Therapeutics Recent Developments and Future Plans
    Table 45. bluebird bio Company Information, Head Office, and Major Competitors
    Table 46. bluebird bio Major Business
    Table 47. bluebird bio Gene Therapy-based Drug Product and Solutions
    Table 48. bluebird bio Gene Therapy-based Drug Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 49. bluebird bio Recent Developments and Future Plans
    Table 50. Sunway Biotech Company Information, Head Office, and Major Competitors
    Table 51. Sunway Biotech Major Business
    Table 52. Sunway Biotech Gene Therapy-based Drug Product and Solutions
    Table 53. Sunway Biotech Gene Therapy-based Drug Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 54. Sunway Biotech Recent Developments and Future Plans
    Table 55. SIBIONO Company Information, Head Office, and Major Competitors
    Table 56. SIBIONO Major Business
    Table 57. SIBIONO Gene Therapy-based Drug Product and Solutions
    Table 58. SIBIONO Gene Therapy-based Drug Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 59. SIBIONO Recent Developments and Future Plans
    Table 60. AnGes Company Information, Head Office, and Major Competitors
    Table 61. AnGes Major Business
    Table 62. AnGes Gene Therapy-based Drug Product and Solutions
    Table 63. AnGes Gene Therapy-based Drug Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 64. AnGes Recent Developments and Future Plans
    Table 65. Orchard Therapeutics Company Information, Head Office, and Major Competitors
    Table 66. Orchard Therapeutics Major Business
    Table 67. Orchard Therapeutics Gene Therapy-based Drug Product and Solutions
    Table 68. Orchard Therapeutics Gene Therapy-based Drug Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 69. Orchard Therapeutics Recent Developments and Future Plans
    Table 70. Human Stem Cells Institute Company Information, Head Office, and Major Competitors
    Table 71. Human Stem Cells Institute Major Business
    Table 72. Human Stem Cells Institute Gene Therapy-based Drug Product and Solutions
    Table 73. Human Stem Cells Institute Gene Therapy-based Drug Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 74. Human Stem Cells Institute Recent Developments and Future Plans
    Table 75. Global Gene Therapy-based Drug Revenue (USD Million) by Players (2019-2024)
    Table 76. Global Gene Therapy-based Drug Revenue Share by Players (2019-2024)
    Table 77. Breakdown of Gene Therapy-based Drug by Company Type (Tier 1, Tier 2, and Tier 3)
    Table 78. Market Position of Players in Gene Therapy-based Drug, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
    Table 79. Head Office of Key Gene Therapy-based Drug Players
    Table 80. Gene Therapy-based Drug Market: Company Product Type Footprint
    Table 81. Gene Therapy-based Drug Market: Company Product Application Footprint
    Table 82. Gene Therapy-based Drug New Market Entrants and Barriers to Market Entry
    Table 83. Gene Therapy-based Drug Mergers, Acquisition, Agreements, and Collaborations
    Table 84. Global Gene Therapy-based Drug Consumption Value (USD Million) by Type (2019-2024)
    Table 85. Global Gene Therapy-based Drug Consumption Value Share by Type (2019-2024)
    Table 86. Global Gene Therapy-based Drug Consumption Value Forecast by Type (2025-2030)
    Table 87. Global Gene Therapy-based Drug Consumption Value by Application (2019-2024)
    Table 88. Global Gene Therapy-based Drug Consumption Value Forecast by Application (2025-2030)
    Table 89. North America Gene Therapy-based Drug Consumption Value by Type (2019-2024) & (USD Million)
    Table 90. North America Gene Therapy-based Drug Consumption Value by Type (2025-2030) & (USD Million)
    Table 91. North America Gene Therapy-based Drug Consumption Value by Application (2019-2024) & (USD Million)
    Table 92. North America Gene Therapy-based Drug Consumption Value by Application (2025-2030) & (USD Million)
    Table 93. North America Gene Therapy-based Drug Consumption Value by Country (2019-2024) & (USD Million)
    Table 94. North America Gene Therapy-based Drug Consumption Value by Country (2025-2030) & (USD Million)
    Table 95. Europe Gene Therapy-based Drug Consumption Value by Type (2019-2024) & (USD Million)
    Table 96. Europe Gene Therapy-based Drug Consumption Value by Type (2025-2030) & (USD Million)
    Table 97. Europe Gene Therapy-based Drug Consumption Value by Application (2019-2024) & (USD Million)
    Table 98. Europe Gene Therapy-based Drug Consumption Value by Application (2025-2030) & (USD Million)
    Table 99. Europe Gene Therapy-based Drug Consumption Value by Country (2019-2024) & (USD Million)
    Table 100. Europe Gene Therapy-based Drug Consumption Value by Country (2025-2030) & (USD Million)
    Table 101. Asia-Pacific Gene Therapy-based Drug Consumption Value by Type (2019-2024) & (USD Million)
    Table 102. Asia-Pacific Gene Therapy-based Drug Consumption Value by Type (2025-2030) & (USD Million)
    Table 103. Asia-Pacific Gene Therapy-based Drug Consumption Value by Application (2019-2024) & (USD Million)
    Table 104. Asia-Pacific Gene Therapy-based Drug Consumption Value by Application (2025-2030) & (USD Million)
    Table 105. Asia-Pacific Gene Therapy-based Drug Consumption Value by Region (2019-2024) & (USD Million)
    Table 106. Asia-Pacific Gene Therapy-based Drug Consumption Value by Region (2025-2030) & (USD Million)
    Table 107. South America Gene Therapy-based Drug Consumption Value by Type (2019-2024) & (USD Million)
    Table 108. South America Gene Therapy-based Drug Consumption Value by Type (2025-2030) & (USD Million)
    Table 109. South America Gene Therapy-based Drug Consumption Value by Application (2019-2024) & (USD Million)
    Table 110. South America Gene Therapy-based Drug Consumption Value by Application (2025-2030) & (USD Million)
    Table 111. South America Gene Therapy-based Drug Consumption Value by Country (2019-2024) & (USD Million)
    Table 112. South America Gene Therapy-based Drug Consumption Value by Country (2025-2030) & (USD Million)
    Table 113. Middle East & Africa Gene Therapy-based Drug Consumption Value by Type (2019-2024) & (USD Million)
    Table 114. Middle East & Africa Gene Therapy-based Drug Consumption Value by Type (2025-2030) & (USD Million)
    Table 115. Middle East & Africa Gene Therapy-based Drug Consumption Value by Application (2019-2024) & (USD Million)
    Table 116. Middle East & Africa Gene Therapy-based Drug Consumption Value by Application (2025-2030) & (USD Million)
    Table 117. Middle East & Africa Gene Therapy-based Drug Consumption Value by Country (2019-2024) & (USD Million)
    Table 118. Middle East & Africa Gene Therapy-based Drug Consumption Value by Country (2025-2030) & (USD Million)
    Table 119. Gene Therapy-based Drug Raw Material
    Table 120. Key Suppliers of Gene Therapy-based Drug Raw Materials
List of Figures
    Figure 1. Gene Therapy-based Drug Picture
    Figure 2. Global Gene Therapy-based Drug Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Figure 3. Global Gene Therapy-based Drug Consumption Value Market Share by Type in 2023
    Figure 4. Viral Gene Delivery System
    Figure 5. Non-viral Gene Delivery System
    Figure 6. Global Gene Therapy-based Drug Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Figure 7. Gene Therapy-based Drug Consumption Value Market Share by Application in 2023
    Figure 8. Neurological Diseases Picture
    Figure 9. Cancer Picture
    Figure 10. Other Picture
    Figure 11. Global Gene Therapy-based Drug Consumption Value, (USD Million): 2019 & 2023 & 2030
    Figure 12. Global Gene Therapy-based Drug Consumption Value and Forecast (2019-2030) & (USD Million)
    Figure 13. Global Market Gene Therapy-based Drug Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
    Figure 14. Global Gene Therapy-based Drug Consumption Value Market Share by Region (2019-2030)
    Figure 15. Global Gene Therapy-based Drug Consumption Value Market Share by Region in 2023
    Figure 16. North America Gene Therapy-based Drug Consumption Value (2019-2030) & (USD Million)
    Figure 17. Europe Gene Therapy-based Drug Consumption Value (2019-2030) & (USD Million)
    Figure 18. Asia-Pacific Gene Therapy-based Drug Consumption Value (2019-2030) & (USD Million)
    Figure 19. South America Gene Therapy-based Drug Consumption Value (2019-2030) & (USD Million)
    Figure 20. Middle East and Africa Gene Therapy-based Drug Consumption Value (2019-2030) & (USD Million)
    Figure 21. Global Gene Therapy-based Drug Revenue Share by Players in 2023
    Figure 22. Gene Therapy-based Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
    Figure 23. Global Top 3 Players Gene Therapy-based Drug Market Share in 2023
    Figure 24. Global Top 6 Players Gene Therapy-based Drug Market Share in 2023
    Figure 25. Global Gene Therapy-based Drug Consumption Value Share by Type (2019-2024)
    Figure 26. Global Gene Therapy-based Drug Market Share Forecast by Type (2025-2030)
    Figure 27. Global Gene Therapy-based Drug Consumption Value Share by Application (2019-2024)
    Figure 28. Global Gene Therapy-based Drug Market Share Forecast by Application (2025-2030)
    Figure 29. North America Gene Therapy-based Drug Consumption Value Market Share by Type (2019-2030)
    Figure 30. North America Gene Therapy-based Drug Consumption Value Market Share by Application (2019-2030)
    Figure 31. North America Gene Therapy-based Drug Consumption Value Market Share by Country (2019-2030)
    Figure 32. United States Gene Therapy-based Drug Consumption Value (2019-2030) & (USD Million)
    Figure 33. Canada Gene Therapy-based Drug Consumption Value (2019-2030) & (USD Million)
    Figure 34. Mexico Gene Therapy-based Drug Consumption Value (2019-2030) & (USD Million)
    Figure 35. Europe Gene Therapy-based Drug Consumption Value Market Share by Type (2019-2030)
    Figure 36. Europe Gene Therapy-based Drug Consumption Value Market Share by Application (2019-2030)
    Figure 37. Europe Gene Therapy-based Drug Consumption Value Market Share by Country (2019-2030)
    Figure 38. Germany Gene Therapy-based Drug Consumption Value (2019-2030) & (USD Million)
    Figure 39. France Gene Therapy-based Drug Consumption Value (2019-2030) & (USD Million)
    Figure 40. United Kingdom Gene Therapy-based Drug Consumption Value (2019-2030) & (USD Million)
    Figure 41. Russia Gene Therapy-based Drug Consumption Value (2019-2030) & (USD Million)
    Figure 42. Italy Gene Therapy-based Drug Consumption Value (2019-2030) & (USD Million)
    Figure 43. Asia-Pacific Gene Therapy-based Drug Consumption Value Market Share by Type (2019-2030)
    Figure 44. Asia-Pacific Gene Therapy-based Drug Consumption Value Market Share by Application (2019-2030)
    Figure 45. Asia-Pacific Gene Therapy-based Drug Consumption Value Market Share by Region (2019-2030)
    Figure 46. China Gene Therapy-based Drug Consumption Value (2019-2030) & (USD Million)
    Figure 47. Japan Gene Therapy-based Drug Consumption Value (2019-2030) & (USD Million)
    Figure 48. South Korea Gene Therapy-based Drug Consumption Value (2019-2030) & (USD Million)
    Figure 49. India Gene Therapy-based Drug Consumption Value (2019-2030) & (USD Million)
    Figure 50. Southeast Asia Gene Therapy-based Drug Consumption Value (2019-2030) & (USD Million)
    Figure 51. Australia Gene Therapy-based Drug Consumption Value (2019-2030) & (USD Million)
    Figure 52. South America Gene Therapy-based Drug Consumption Value Market Share by Type (2019-2030)
    Figure 53. South America Gene Therapy-based Drug Consumption Value Market Share by Application (2019-2030)
    Figure 54. South America Gene Therapy-based Drug Consumption Value Market Share by Country (2019-2030)
    Figure 55. Brazil Gene Therapy-based Drug Consumption Value (2019-2030) & (USD Million)
    Figure 56. Argentina Gene Therapy-based Drug Consumption Value (2019-2030) & (USD Million)
    Figure 57. Middle East and Africa Gene Therapy-based Drug Consumption Value Market Share by Type (2019-2030)
    Figure 58. Middle East and Africa Gene Therapy-based Drug Consumption Value Market Share by Application (2019-2030)
    Figure 59. Middle East and Africa Gene Therapy-based Drug Consumption Value Market Share by Country (2019-2030)
    Figure 60. Turkey Gene Therapy-based Drug Consumption Value (2019-2030) & (USD Million)
    Figure 61. Saudi Arabia Gene Therapy-based Drug Consumption Value (2019-2030) & (USD Million)
    Figure 62. UAE Gene Therapy-based Drug Consumption Value (2019-2030) & (USD Million)
    Figure 63. Gene Therapy-based Drug Market Drivers
    Figure 64. Gene Therapy-based Drug Market Restraints
    Figure 65. Gene Therapy-based Drug Market Trends
    Figure 66. Porters Five Forces Analysis
    Figure 67. Manufacturing Cost Structure Analysis of Gene Therapy-based Drug in 2023
    Figure 68. Manufacturing Process Analysis of Gene Therapy-based Drug
    Figure 69. Gene Therapy-based Drug Industrial Chain
    Figure 70. Methodology
    Figure 71. Research Process and Data Source

Companies Mentioned

Biogen
Novartis
Gilead Sciences
Sarepta Therapeutics
Alnylam Pharmaceuticals
Amgen
Spark Therapeutics
Akcea Therapeutics
bluebird bio
Sunway Biotech
SIBIONO
AnGes
Orchard Therapeutics
Human Stem Cells Institute